BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 15176082)

  • 1. Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites.
    Kalamatianos T; Kalló I; Piggins HD; Coen CW
    J Comp Neurol; 2004 Jul; 475(1):19-35. PubMed ID: 15176082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic approach reveals expression of the VPAC2 receptor in phenotypically defined neurons in the mouse suprachiasmatic nucleus and in its efferent target sites.
    Kalló I; Kalamatianos T; Wiltshire N; Shen S; Sheward WJ; Harmar AJ; Coen CW
    Eur J Neurosci; 2004 Apr; 19(8):2201-11. PubMed ID: 15090046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats.
    Kalló I; Kalamatianos T; Piggins HD; Coen CW
    J Neuroendocrinol; 2004 Sep; 16(9):758-66. PubMed ID: 15344914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct localization of prokineticin 2 and prokineticin receptor 2 mRNAs in the rat suprachiasmatic nucleus.
    Masumoto KH; Nagano M; Takashima N; Hayasaka N; Hiyama H; Matsumoto S; Inouye ST; Shigeyoshi Y
    Eur J Neurosci; 2006 Jun; 23(11):2959-70. PubMed ID: 16819985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efferent projections of the suprachiasmatic nucleus based on the distribution of vasoactive intestinal peptide (VIP) and arginine vasopressin (AVP) immunoreactive fibers in the hypothalamus of Sapajus apella.
    Campos LM; Cruz-Rizzolo RJ; Watanabe IS; Pinato L; Nogueira MI
    J Chem Neuroanat; 2014 May; 57-58():42-53. PubMed ID: 24727411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal polypeptide (VIP) phase-shifts the rat suprachiasmatic nucleus clock in vitro.
    Reed HE; Meyer-Spasche A; Cutler DJ; Coen CW; Piggins HD
    Eur J Neurosci; 2001 Feb; 13(4):839-43. PubMed ID: 11207820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of VPAC2 receptor activation on membrane excitability and GABAergic transmission in subparaventricular zone neurons targeted by suprachiasmatic nucleus.
    Hermes ML; Kolaj M; Doroshenko P; Coderre E; Renaud LP
    J Neurophysiol; 2009 Sep; 102(3):1834-42. PubMed ID: 19571188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
    Basille M; Vaudry D; Coulouarn Y; Jegou S; Lihrmann I; Fournier A; Vaudry H; Gonzalez B
    J Comp Neurol; 2000 Oct; 425(4):495-509. PubMed ID: 10975876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timed hypocaloric food restriction alters the synthesis and expression of vasopressin and vasoactive intestinal peptide in the suprachiasmatic nucleus.
    Andrade JP; Pereira PA; Silva SM; Sá SI; Lukoyanov NV
    Brain Res; 2004 Oct; 1022(1-2):226-33. PubMed ID: 15353233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin neurons form a distinct peptidergic neuronal group in the rat suprachiasmatic nucleus: a double labeling in situ hybridization study.
    Tanaka M; Okamura H; Matsuda T; Shigeyoshi Y; Hisa Y; Chihara K; Ibata Y
    Neurosci Lett; 1996 Sep; 215(2):119-22. PubMed ID: 8888010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine-vasopressin and vasointestinal polypeptide rhythms in the suprachiasmatic nucleus of the mouse lemur reveal aging-related alterations of circadian pacemaker neurons in a non-human primate.
    Cayetanot F; Bentivoglio M; Aujard F
    Eur J Neurosci; 2005 Aug; 22(4):902-10. PubMed ID: 16115213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells.
    Fukuchi M; Sakuragawa S; Tabuchi A; Tsuda M
    J Neurosci Res; 2004 Jul; 77(1):26-34. PubMed ID: 15197736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
    Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo L; Nussdorfer GG
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2575-80. PubMed ID: 12050216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target areas innervated by PACAP-immunoreactive retinal ganglion cells.
    Hannibal J; Fahrenkrug J
    Cell Tissue Res; 2004 Apr; 316(1):99-113. PubMed ID: 14991397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery.
    Boni LJ; Ploug KB; Olesen J; Jansen-Olesen I; Gupta S
    Cephalalgia; 2009 Aug; 29(8):837-47. PubMed ID: 19220306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.